Press Releases

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Posted on July 25, 2024

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

Posted on July 25, 2024

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government’s Innovative Licensing and Access Pathway

Posted on July 11, 2024

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer

Posted on July 2, 2024

INOVIO Added to Russell 2000® Index Effective July 1, 2024

Posted on July 1, 2024

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

Posted on June 4, 2024

INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights

Posted on May 13, 2024

INOVIO to Participate in Upcoming Investor Conferences in May

Posted on April 29, 2024

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024

Posted on April 29, 2024

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Posted on April 15, 2024

© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.